This Edition
ARTICLE | Clinical News
NNZ-2566: Phase IIa start
WIR Staff
May 14, 2007 7:00 AM UTC
In 1Q08, NEU will begin an open-label, U.S. Phase IIa trial in 40-50 patients. ...